- Lupin to acquire Gavis Pharmaceuticals (chaindrugreview.com)
Lupin Ltd. plans to buy Gavis Pharmaceuticals LLC and Novel Laboratories Inc. in an $880 million deal….the acquisition will boost its scale in the U.S. generic drug market and broadens its pipeline in dermatology, controlled-substance products, and other high-value and niche generics… Lupin is the fifth-largest generics player in the United States and the third-largest Indian pharmaceutical company by sales.
- One big myth about medicine: We know how drugs work (washingtonpost.com)
Here’s how we think we discover powerful new medicines: Scientists dig deep into biology and zero in on a molecular Achilles’ heel that could disable a devastating disease,..They concoct experimental drugs that hit the target....Here’s how we actually develop...treatments: good old-fashioned observation, trial and error, and luck
- Stony Brook School of Pharmacy and Pharmaceutical Sciences (pharmacytimes.com)
Stony Brook’s pharmacy school is still pending, but prospective students may want to keep an eye on this option for 2017...in the works for 4 years...national need for pharmacists and the academic and clinical environment at Stony Brook Medicine prompted the idea for a new school (Q&A)
- Malaria vaccine Mosquirix gets European approval (cbc.ca)
first malaria vaccine got a green light... from European drugs regulators who recommended it as safe and effective to use in babies in Africa at risk of the mosquito-borne disease....called RTS,S or Mosquirix, and developed by GlaxoSmithKline in partnership with the PATH Malaria Vaccine Initiative, would be the first licensed human vaccine against a parasitic disease and could help prevent millions of cases of malaria...
- Why insurers should negotiate with manufacturers for better drug prices (fiercehealthpayer.com)
federal government could save anywhere between $15.2 billion and $16 billion annually if it negotiated Medicare Part D prescription prices with drug makers, … the high levels of deductibles and out-of-pocket copayments are the main reason why so many Americans cannot afford to fill their prescriptions…federal government cannot directly negotiate rebates due to the non-interference clause,…but insurers can.
- Pharmacy Week in Review: July 24, 2015 (pharmacytimes.com)
Ashley Talamo, Publisher: Pharmacy Times...(PTNN) This weekly video program highlights the latest in pharmacy news, product news, and more. (video)
- New Retrovirus Screening Test Launched by Roche (pharmacytimes.com)
Roche has launched a diagnostic assay designed to identify Human T-lymphotropic virus I/II in donated blood or routine samples....reducing transmission risk and improving blood safety...and timely supply of blood products...currently no treatment to eliminate HTLV from the body..
- Panel: Despite health industry advances, education remains in ‘Dark Ages’ (fiercehealthit.com)
Healthcare education is still "back in the Dark Ages," and as new advances in information and technology change the industry, the way the workforce learns and is educated also needs a reboot,...
- Pharmacy Compounding Missouri Lethal Injections Must Be Publicized (pharmacytimes.com)
Missouri Department of Corrections has violated the state’s Sunshine Law by refusing to reveal the name of a pharmacy that compounds lethal injections,...compounding pharmacy ....provide pentobarbital for executions.
- Robotic Pills Could Simplify Administration of Biologic Drugs (pharmacytimes.com)
robotic pill may be the first oral agent to successfully traverse the acidic digestive environment to deliver biologic drugs that, to date, could only be delivered via injection. The pill would facilitate..administration of complex biotech drugs.. ingestible technology increasing convenience...supporting adherence...communicates to caretakers and providers whether a patient has taken his or her doses..









